New drug tested for rare 'Cold Allergy' disease
Disease control
Recruiting now
This early-stage study is testing a new drug called JTE-162 for people with Cryopyrin-Associated Periodic Syndrome (CAPS), a rare genetic inflammatory disease. The study will check if the drug is safe and if it reduces inflammation and symptoms like rash, joint pain, and fever. O…
Phase: PHASE1 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC